Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 11, 2016 - Issue 1
Submit an article Journal homepage
715
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies

Judith R HombergDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands
,
Evan J KyzarDepartment of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA;The International Stress and Behavior Society (ISBS), Kiev, Ukraine
,
Adam Michael StewartZENEREI Research Center, Slidell, LA, USA
,
Michael NguyenZENEREI Research Center, Slidell, LA, USA
,
Manoj K PoudelZENEREI Research Center, Slidell, LA, USA
,
David J EchevarriaThe International Stress and Behavior Society (ISBS), Kiev, Ukraine;Department of Psychology, University of Southern Mississippi, Hattiesburg, MS, USA
,
Adam D CollierDepartment of Psychology, University of Southern Mississippi, Hattiesburg, MS, USA
,
Siddharth GaikwadThe International Stress and Behavior Society (ISBS), Kiev, Ukraine;Research Institute of Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong, China;Neuroscience Graduate Hospital, China Medical University Hospital, Taichung, Taiwan
,
Viktor M KlimenkoThe International Stress and Behavior Society (ISBS), Kiev, Ukraine;Pavlov Physiology Department, Institute of Experimental Medicine, St. Petersburg, Russia
,
William NortonDepartment of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK
,
Julian PittmanDepartment of Biological and Environmental Sciences, Troy University, Troy, AL, USA
,
Shun NakamuraThe International Stress and Behavior Society (ISBS), Kiev, Ukraine;Tokyo University of Agriculture and Technology, Tokyo, Japan
,
Mamiko KoshibaThe International Stress and Behavior Society (ISBS), Kiev, Ukraine;Departments of Pediatrics and Biochemistry, Saitama University Medical School, Saitama, Japan
,
Hideo YamanouchiDepartments of Pediatrics and Biochemistry, Saitama University Medical School, Saitama, Japan
,
Sergey A ApryatinInstitute of Nutrition RAS, Moscow, Russia
,
Maria Luisa ScattoniDepartment of Cell Biology and Neurosciences, Istituto Superiore di Sanita, Rome, Italy
,
David M DiamondDepartment of Psychology, University of South Florida, Tampa, FL, USA;Research and Development Service, J.A. Haley Veterans Hospital, Tampa, FL, USA
,
Jeremy FP UllmannCentre for Advanced Imaging, University of Queensland, Brisbane, Queensland, Australia
,
Matthew O ParkerSchool of Health Sciences and Social Work, University of Portsmouth, Portsmouth, UK
,
Richard E BrownDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada
,
Cai SongResearch Institute of Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong, China;Neuroscience Graduate Hospital, China Medical University Hospital, Taichung, Taiwan;Department of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada
&
Allan V KalueffResearch Institute of Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, Guangdong, China;Institute for Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia;Institute of Chemical Technology and Institute of Natural Sciences, Ural Federal University, Ekaterinburg, RussiaCorrespondence[email protected]
 show all
Pages 11-25 | Published online: 02 Dec 2015

Bibliography

  • Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
  • American Psychiatric Association Force DSMT. Diagnostic and statistical manual of mental disorders: DSM-5. Washington (DC): American Psychiatric Publishing; 2013.
  • Hansen RL, Rogers SJ, Publishing AP. Autism and other neurodevelopmental disorders. New York (NY): Nature Publishing Group; 2013.
  • Ding B. Gene expression in maturing neurons: regulatory mechanisms and related neurodevelopmental disorders. Sheng Li Xue Bao: [Acta Physiologica Sinica]. 2015;67(2):113–133.
  • Frederick AL, Stanwood GD. Drugs, biogenic amine targets and the developing brain. Dev Neurosci. 2009;31(1–2):7–22.
  • Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108(Suppl 3):511–533.
  • Hu WF, Chahrour MH, Walsh CA. The diverse genetic landscape of neurodevelopmental disorders. Annu Rev Genomics Hum Genet. 2014;15:195–213.

•• An excellent review of genetic factors underlying NDDs.

  • Ghosh A, Michalon A, Lindemann L, et al. Drug discovery for autism spectrum disorder: challenges and opportunities. Nature Rev Drug Discovery. 2013;12(10):777–790.

•• A timely and comprehensive review of pharmacotherapeutic strategies to treat autism.

  • Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636–645.
  • Congdon E, Poldrack RA, Freimer NB. Neurocognitive phenotypes and genetic dissection of disorders of brain and behavior. Neuron. 2010;68(2):218–230.
  • Frazer KA, Murray SS, Schork NJ, et al. Human genetic variation and its contribution to complex traits. Nat Reviews Genet. 2009;10(4):241–251.
  • Mitchell K, Porteus DJ. Rethinking the genetic architecture of schizophrenia. Psychol Med. 2011;41:19–32.
  • Arcos-Burgos M, Jain M, Acosta MT, et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry. 2010;15(11):1053–1066.
  • Lange M, Norton W, Coolen M, et al. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol Psychiatry. 2012;17(9):946–954.

• An interesting translational study using human ADHD susceptibility candidate gene in a zebrafish model of this disorder.

  • Elia J, Gai X, Xie HM, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry. 2009;15(6):637–646.
  • Lesch KP, Selch S, Renner TJ, et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry. 2011;16(5):491–503.
  • Lionel AC, Crosbie J, Barbosa N, et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med. 2011;3(95):95ra75.
  • Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet. 2010;376(9750):1401–1408.
  • Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009;25(12):528–535.
  • Walsh CA. Genetic malformations of the human cerebral cortex. Neuron. 1999;23(1):19–29.
  • Walsh CA, Engle EC. Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron. 2010;68(2):245–253.
  • Porteous DJ, Millar JK, Brandon NJ, et al. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med. 2011;17(12):699–706.
  • Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497–507.
  • Grace AA. Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotoxicity Research. 2010;18(3–4):367–376.
  • Leonard JR, Klocke BJ, D’Sa C, et al. Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice. J Neuropathol Exp Neurol. 2002;61(8):673–677.
  • Mitchell K. The miswired brain: making connections from neurodevelopment to psychopathology. BMC Biology. 2011;9:23.
  • Thornton GK, Woods CG. Primary microcephaly: do all roads lead to Rome? Trends Genet. 2009;25(11):501–510.
  • Valiente M, Marin O. Neuronal migration mechanisms in development and disease. Curr Opin Neurobiol. 2010;20(1):68–78.
  • Waddington CH. The strategy of genes. London: George Allen & Unwin; 1957.
  • Lisman JE, Coyle JT, Green RW, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31(5):234–242.
  • Casey BJ, Oliveri ME, Insel T. A neurodevelopmental perspective on the research domain criteria (RDoC) framework. Biol Psychiatry. 2014;76:350–353.

•• An important summary of the research domain criteria (RDoCs) concept that targets the cross-disorder nosology (rather than specific symptoms) of psychiatric disorders.

  • Sforazzini F, Bertero A, Dodero L, et al. Altered functional connectivity networks in acallosal and socially impaired BTBR mice. Brain Struct Funct. Forthcoming 2014.
  • Ceponiene R, Lepistö T, Shestakova A, et al. Speech-sound-selective auditory impairment in children with autism: they can perceive but do not attend. Proc Natl Acad Sci U S A. 2003;100(9):5567–5572.
  • Miller JA, Ding S-L, Sunkin SM, et al. Transcriptional landscape of the prenatal human brain. Nature. 2014;508:199–206.

•• An outstanding, anatomically comprehensive atlas of the mid-gestational human brain, including in situ hybridization, high-resolution magnetic resonance imaging and microarray analyses.

  • Stefansson H, Meyer-Lindenberg A, Steinberg S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505(7483):361–366.
  • Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015;16(9):551–563.
  • Jaffe AE, Shin J, Collado-Torres L, et al. Developmental regulation of human cortex transcription and its clinical relevance at single base resolution. Nat Neurosci. 2015;18(1):154–161.

• An important recent study showing conserved molecular signatures of transcriptional dynamics across brain development, with potential high clinical relevance.

  • Birnbaum R, Jaffe AE, Hyde TM, et al. Prenatal expression patterns of genes associated with neuropsychiatric disorders. Am J Psychiatry. 2014;171(7):758–767.

•• An important study showing the link between common neuropsychiatric disorders and upregulated prenatal gene expression, implicating neurodevelopmental trajectories in brain deficits, including common NDDs, such as ID and ASD.

  • Mazin P, Xiong J, Liu X, et al. Widespread splicing changes in human brain development and aging. Molecular Systems Biology. 2013;9:633.
  • Lambert N, Wermenbol V, Pichon B, et al. A familial heterozygous null mutation of MET in autism spectrum disorder. Autism Res. 2014;7(5):617–622.
  • Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav. 2006;5(2):113–119.
  • Bernstein B, Birney E, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
  • Jiang Y, Yuen R, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet. 2013;93:249–263.
  • Michaelson J, Shi Y, Gujral M, et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell. 2012;151:1431–1442.
  • Hansen R, Gartler S, Scott C, et al. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet. 1992;1:571–578.
  • Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23: 185–188.
  • De Rubeis S, He X, Goldberg A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515:209–215.
  • Feinberg A, Irizarry R. Stochastic epigenetic variation as a driving force ofdevelopment, evolutionary adaptation, and disease. Proc Natl Acad Sci. 2010;107:1757–1764.
  • Jones LJ, Norton WH. Using zebrafish to uncover the genetic and neural basis of aggression, a frequent comorbid symptom of psychiatric disorders. Behav Brain Res. 2015;276:171–180.
  • Arnedo J, Svrakic DM, Del Val C, et al. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry. 2015;172(2):139–153.

• An important study on the emerging “bigger” complexity of neuropsychiatric disorders.

  • Heard E, Martienssen R. Transgenerational epigenetic inheritance: myths and mechanisms. Cell. 2014;157: 95–109.
  • Robison A, Vialou V, Sun H-S, et al. Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects. Neuropsychopharmacology. 2014;39(5):1178–1186.
  • Sweatt JD. Experience-dependent epigenetic modifications in the central nervous system. Biol Psychiatry. 2009;65(3):191–197.
  • Mellen M, Ayata P, Dewell S, et al. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151:1417–1430.
  • Zhubi A, Cook E, Guidotti A, et al. Epigenetic mechanisms in autism spectrum disorder. Int Rev Neurobiol. 2014;115:203–244.
  • Kalueff AV, Olivier JD, Nonkes LJ, et al. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev. 2010;34(3):373–386.

• A timely discussion on the role of serotonin and serotonin transporter in translational models of brain disorders, including NDDs.

  • Altieri SC, Yang H, O’Brien HJ, et al. Perinatal vs genetic programming of serotonin states associated with anxiety. Neuropsychopharmacology. 2015;40(6):1456–1470.
  • Kepser LJ, Homberg JR. The neurodevelopmental effects of serotonin: a behavioural perspective. Behav Brain Res. 2015;277:3–13.

• An important discussion of developmental, neurotrophic role of serotonin, highly relevant to NDDs.

  • Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68(11):1104–1112.
  • El Marroun H, White TJ, Van Der Knaap NJ, et al. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. British J Psychiatry. 2014;205(2):95–102.
  • Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol. 2012;4(3):a009886.
  • De Rubeis S, He X, Goldberg A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515:209–215.
  • Clayton J, Collins F. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509:282–283.
  • Stewart AM, Kalueff AV. Anxiolytic drug discovery: what are the novel approaches and how can we improve them? Expert Opin Drug Discov. 2014;9(1):15–26.
  • Holmes EA, Craske MG, Graybiel AM. Psychological treatments: a call for mental-health science. Nature. 2014;511(7509):287–289.
  • Van Der Voet M, Harich B, et al. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila. Mol Psychiatry. Forthcoming 2015.
  • Kalueff AV, Echevarria DJ, Stewart AM. Gaining translational momentum: more zebrafish models for neuroscience research. Prog Neuropsychopharmacol Biol Psychiatry. 2014;55:1–6.
  • Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci. 2014;35(2):63–75.
  • Kalueff AV, Gebhardt M, Stewart AM, et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish. 2013;10(1):70–86.
  • Stewart AM, Nguyen M, Wong K, et al. Developing zebrafish models of autism spectrum disorder (ASD). Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:27–36.
  • Lange M, Norton W, Coolen M, et al. The ADHD-linked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish. Mol Psychiatry. 2012;17(9):855.
  • Lange M, Norton W, Coolen M, et al. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol Psychiatry. 2012;17(9):946–954.
  • Koshiba M, Karino G, Senoo A, et al. Peer attachment formation by systemic redox regulation with social training after a sensitive period. Sci Rep. 2013;3:2503.
  • Shirakawa YN, Koshiba M. Peer-Social Network Development Revealed by the Brain Multivariate Correlation Map with 10 Monoamines and 11 Behaviors. J Clin Toxicol. 2013;3(2):1000161.

•• An important translational “integrative” study linking animal social behaviors/learning to brain neurochemical phenotypes.

  • Koshiba MN, Mimura K, Senoo A, et al. Socio-emotional development evaluated by Behaviour Output analysis for Quantitative Emotional State Translation: towards early diagnosis of individuals with developmental disorders. OA Autism. 2013;1(2):18.
  • Koshiba M, Mimura K, Sugiura Y, et al. Reading marmoset behavior “semantics” under particular social context by multi-parameters correlation analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(6):1499–1504.
  • Koshiba M, Senoo A, Mimura K, et al. A cross-species socio-emotional behaviour development revealed by a multivariate analysis. Sci Rep. 2013;3:2630.
  • Kaur K, Simon AF, Chauhan V, et al. Effect of bisphenol A on Drosophila melanogaster behavior—a new model for the studies on neurodevelopmental disorders. Behav Brain Res. 2015;284:77–84.
  • Wise A, Tenezaca L, Fernandez RW, et al. Drosophila mutants of the autism candidate gene neurobeachin (rugose) exhibit neuro-developmental disorders, aberrant synaptic properties, altered locomotion, and impaired adult social behavior and activity patterns. J Neurogenet. 2015;14:1–9.
  • Mohammed AH, Henriksson BG, Söderström S, et al. Environmental influences on the central nervous system and their implications for the aging rat. Behav Brain Res. 1993;57(2):183–191.
  • Inoue T, Majid T, Pautler RG. Manganese enhanced MRI (MEMRI): neurophysiological applications. Rev Neurosciences. 2011;22(6):675–694.
  • Schneider T, Turczak J, Przewłocki R. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology. 2006;31(1):36–46.
  • Hannigan JH, Berman RF, Zajac CS. Environmental enrichment and the behavioral effects of prenatal exposure to alcohol in rats. Neurotoxicol Teratol. 1993;15(4):261–266.
  • Berman RF, Hannigan JH, Sperry MA, et al. Prenatal alcohol exposure and the effects of environmental enrichment on hippocampal dendritic spine density. Alcohol. 1996;13(2):209–216.
  • Wainwright P, Levesque S, Krempulec L, et al. Effects of environmental enrichment on cortical depth and Morris-maze performance in B6D2F 2 mice exposed prenatally to ethanol. Neurotoxicol Teratol. 1993;15(1):11–20.
  • Del Arco A, Segovia G, Canales J, et al. Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat. J Neural Transm. 2007;114:43–48.
  • Pamplona FA, Pandolfo P, Savoldi R, et?al. Environmental enrichment improves cognitive deficits in spontaneously hypertensive rats (SHR): relevance for attention deficit/hyperactivity disorder (ADHD). Prog Neuro-Psychopharmacology Biol Psychiatry. 2009;33(7):1153–1160.
  • Perry JL, Stairs DJ, Bardo MT. Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate. Behav Brain Res. 2008;193(1):48–54.
  • Jaffee SR, Price TS. Gene-environment correlations: a review of the evidence and implications for prevention of mental illness. Mol Psychiatry. 2007;12(5):432–442.
  • Ullmann JFP, Cowin G, Kurniawan ND, et al. A three-dimensional digital atlas of the zebrafish brain. NeuroImage. 2010;51(1):76–82.
  • Ullmann JFP, Cowin G, Collin SP. Quantitative assessment of brain volumes in fish: comparison of methodologies. Brain Behav Evol. 2010;76:261–270.
  • Ullmann JF, Watson C, Janke AL, et al. An MRI atlas of the mouse basal ganglia. Brain Struct Funct. 2014;219(4):1343–1353.
  • Richards KL, Kurniawan ND, Yang Z, et al. Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy. Neurology. 2013;80(13):1240–1246.
  • Calabrese E, Johnson GA, Watson C. An ontology-based segmentation scheme for tracking postnatal changes in the developing rodent brain with MRI. NeuroImage. 2013;67:375–384.
  • Allsop SA, Vander Weele CM, Wichmann R, et al. Optogenetic insights on the relationship between anxiety-related behaviors and social deficits. Front Behav Neurosci. 2014;8:241.
  • Yizhar O. Optogenetic insights into social behavior function. Biol Psychiatry. 2012;71(12):1075–1080.
  • Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci. 2012;13(4):251–266.
  • Wong DF, Tauscher J, Grunder G. The role of imaging in proof of concept for CNS drug discovery and development. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2009;34(1):187–203.
  • Beckmann N, Kneuer R, Gremlich HU, et al. In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed. 2007;20(3):154–185.
  • Chung K, Wallace J, Kim SY, et al. Structural and molecular interrogation of intact biological systems. Nature. 2013;497(7449):332–337.
  • Onnink AM, Zwiers MP, Hoogman M, et al. Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance. Prog Neuropsychopharmacol Biol Psychiatry. 2015;63:14–22.
  • Chiang HL, Chen YJ, Lo YC, et al. Altered white matter tract property related to impaired focused attention, sustained attention, cognitive impulsivity and vigilance in attention-deficit/ hyperactivity disorder. J Psychiatry Neurosci. 2015;40(2):140106.

• An interesting study showing potential neuroanatomical white matter-related biomarkers of NDDs.

  • Bremner JD, Vythilingam M, Vermetten E, et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry. 2003;160(5):924–932.
  • Bremner JD. Long-term effects of childhood abuse on brain and neurobiology. Child Adolesc Psychiatr Clin N Am. 2003;12(2):271–292.
  • Asnis GM, Kohn SR, Henderson M, et al. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs. 2004;64(4):383–404.
  • Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159(10):1777–1779.
  • Southwick SM, Morgan CA, Charney DS, et al. Yohimbine use in a natural setting: effects on posttraumatic stress disorder. Biol Psychiatry. 1999;46(3):442–444.
  • Pitman RK, Sanders KM, Zusman RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51(2):189–192.
  • Zoladz PR, Park CR, Munoz C, et al. Tianeptine: an antidepressant with memory-protective properties. Curr Neuropharmacol. 2008;6(4):311–321.
  • Stewart AM, Kalueff AV. Developing better and more valid animal models of brain disorders. Behav Brain Res. 2015;276:28–31.
  • Kalueff AV, Murphy DL. The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plast. 2007;2007:52087.
  • Kalueff AV, Wheaton M, Murphy DL. What’s wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007;179(1):1–18.
  • Sullivan PF. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med. 2012;18(2):210–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.